3PC-020 Prevention of infectious risk in patients treated with tumour necrosis factor alpha inhibitors (anti-TNFα)

ZRibera Ruiz De Vergara; AI Idoate Grijalba; L Cabia Fernández; M De Miguel Gaztelu

doi:10.1136/ejhpharm-2024-eahp.77

Article info

PDF

Section 3: Production and compounding

3PC-020 Prevention of infectious risk in patients treated with tumour necrosis factor alpha inhibitors (anti-TNFα)

Authors

ZRibera Ruiz De Vergara Hospital García Orcoyen, Pharmacy Service, Estella- Navarra, Spain PubMed articles Google scholar articles
AI Idoate Grijalba Hospital García Orcoyen, Pharmacy Service, Estella- Navarra, Spain PubMed articles Google scholar articles
L Cabia Fernández Hospital García Orcoyen, Pharmacy Service, Estella- Navarra, Spain PubMed articles Google scholar articles
M De Miguel Gaztelu Central Services, Primary Care Pharmacy, Pamplona- Navarra, Spain PubMed articles Google scholar articles

Citation

Ruiz De Vergara Z, Idoate Grijalba A, Cabia Fernández L, et al

3PC-020 Prevention of infectious risk in patients treated with tumour necrosis factor alpha inhibitors (anti-TNFα)

European Journal of Hospital Pharmacy 2024;31:A37-A38.

Publication history

First published March 20, 2024.

Online issue publication

March 20, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password